Wednesday, October 15, 2025 12:49:33 PM
Estimated $NVAX buyout range is $3.5B-$7.2B Per AI (Grok & ChatGPT5). Current market cap = $1.47B. #biotech $XBI $IBB pic.twitter.com/hYRXdsRgiX
— JonSkiJr74 (@Jr74Ski) October 15, 2025
Recent NVAX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 10:13:36 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/09/2026 10:12:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:04:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:03:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:02:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:01:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:37:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:35:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:34:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:33:22 AM
- Novavax to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/26/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:02:10 PM
- Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights • PR Newswire (US) • 02/26/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:33:51 PM
- Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • PR Newswire (US) • 02/19/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 12:57:59 AM
- Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer • IH Market News • 01/20/2026 02:48:06 PM
- Novavax Announces Entering into a License Agreement with Pfizer • PR Newswire (US) • 01/20/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 11:59:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:01:06 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
